Table 1. Patient and disease... | American Society of Hematology

Table 1.

Patient and disease characteristics

Patient no.	Age (y)	Sex	Disease	Status	Previous autograft	Time to transplantation (mo)^*	Stem cell source	HLA mismatch
1	45	M	HGNHL	PR	Yes	73	BM	1 Ag C^†
2	38	M	HGNHL	PR	Yes	17	BM	—
3	18	M	ALL	CR 2	Yes	29	BM	—
4	30	M	AML	CR 2	Yes	23	BM	—^†
5	44	F	AML	CR 2	Yes	14	BM	—
6	30	F	HD	Refractory	Yes	189	BM	—
7	35	M	PCL	CR 1	No	9	BM	1 Ag DQB1
8	22	F	HD	PR	Yes	32	BM	—
9	53	F	CML	CP1	No	34	BM	1 Ag C^†
10	42	F	MM	PR	No	8	BM	2 Ag C, 1 Ag DQB1
11	30	F	2° AML	PR	Yes	46	BM	—
12	47	M	MM	PR	No	9	BM	1 Ag DQB1
13	31	M	HD	PR	Yes	65	BM	—^†
14	20	M	HGNHL	CR 2	Yes	44	BM	—^†
15	27	F	ALL	CR 2	Yes	17	BM	—
16	27	M	LGNHL	PR	No	8	BM	—
17	35	M	LGNHL	PR	Yes	65	BM	1 Ag DRB1
18	34	M	MM	PR	No	6	BM	—
19	40	M	LGNHL	PR	Yes	133	BM	—
20	44	F	MM	Refractory	Yes	4	BM	—
21	18	F	HGNHL	PR	Yes	26	BM	1 Ag DQB1
22	44	F	HGNHL	PR	Yes	51	BM	—
23	36	M	CML	CP1	No	51	BM	—
24	31	F	HD	PR	Yes	56	BM	—
25	39	F	AML	CR 2	No	18	BM	1 Ag C^†
26	47	M	MM	PR	No	7	BM	1 Ag C
27	44	M	MM	Refractory	Yes	23	BM	1 Ag DQB1^†
28	50	F	T-PLL	PR	No	10	BM	—
29	54	M	AML	CR 2	No	24	BM	—
30	62	M	CMML	PR	No	13	BM	1 Ag A^†
31	52	M	MM	PR	No	51	BM	1 Ag C
32	44	F	HGNHL	PR	Yes	29	BM	—
33	52	M	MCL	PR	Yes	76	BM	—
34	29	F	LGNHL	CR 3	Yes	66	BM	—
35	40	F	AML	CR 2	Yes	26	BM	1 Ag A^†
36	56	F	MCL	PR	No	49	BM	1 Ag DQB1
37	47	M	MM	PR	No	6	BM	—
38	44	F	MM	Refractory	Yes	15	BM	1 Ag C
39	55	M	HGNHL	PR	Yes	20	BM	—
40	44	M	MCL	PR	No	61	BM	—
41	46	M	HGNHL	CR 2	Yes	44	BM	1 Ag C, 1 Ag DQB1^‡
42	50	M	CML	CP1	No	21	BM	1 Ag DRB1
43	41	M	CML	CP1	Yes	43	BM	1 Ag B, 1 Ag DQB1^†
44	49	M	MM	PR	Yes	70	PBSCs	1 Ag C, 1 Ag DQB1^†
45	48	F	CML	CP1	No	21	BM	1 Ag C^†
46	38	M	HD	PR	Yes	83	BM	—
47	47	F	MM	PR	Yes	36	BM	^†

Patient no.	Age (y)	Sex	Disease	Status	Previous autograft	Time to transplantation (mo)^*	Stem cell source	HLA mismatch
1	45	M	HGNHL	PR	Yes	73	BM	1 Ag C^†
2	38	M	HGNHL	PR	Yes	17	BM	—
3	18	M	ALL	CR 2	Yes	29	BM	—
4	30	M	AML	CR 2	Yes	23	BM	—^†
5	44	F	AML	CR 2	Yes	14	BM	—
6	30	F	HD	Refractory	Yes	189	BM	—
7	35	M	PCL	CR 1	No	9	BM	1 Ag DQB1
8	22	F	HD	PR	Yes	32	BM	—
9	53	F	CML	CP1	No	34	BM	1 Ag C^†
10	42	F	MM	PR	No	8	BM	2 Ag C, 1 Ag DQB1
11	30	F	2° AML	PR	Yes	46	BM	—
12	47	M	MM	PR	No	9	BM	1 Ag DQB1
13	31	M	HD	PR	Yes	65	BM	—^†
14	20	M	HGNHL	CR 2	Yes	44	BM	—^†
15	27	F	ALL	CR 2	Yes	17	BM	—
16	27	M	LGNHL	PR	No	8	BM	—
17	35	M	LGNHL	PR	Yes	65	BM	1 Ag DRB1
18	34	M	MM	PR	No	6	BM	—
19	40	M	LGNHL	PR	Yes	133	BM	—
20	44	F	MM	Refractory	Yes	4	BM	—
21	18	F	HGNHL	PR	Yes	26	BM	1 Ag DQB1
22	44	F	HGNHL	PR	Yes	51	BM	—
23	36	M	CML	CP1	No	51	BM	—
24	31	F	HD	PR	Yes	56	BM	—
25	39	F	AML	CR 2	No	18	BM	1 Ag C^†
26	47	M	MM	PR	No	7	BM	1 Ag C
27	44	M	MM	Refractory	Yes	23	BM	1 Ag DQB1^†
28	50	F	T-PLL	PR	No	10	BM	—
29	54	M	AML	CR 2	No	24	BM	—
30	62	M	CMML	PR	No	13	BM	1 Ag A^†
31	52	M	MM	PR	No	51	BM	1 Ag C
32	44	F	HGNHL	PR	Yes	29	BM	—
33	52	M	MCL	PR	Yes	76	BM	—
34	29	F	LGNHL	CR 3	Yes	66	BM	—
35	40	F	AML	CR 2	Yes	26	BM	1 Ag A^†
36	56	F	MCL	PR	No	49	BM	1 Ag DQB1
37	47	M	MM	PR	No	6	BM	—
38	44	F	MM	Refractory	Yes	15	BM	1 Ag C
39	55	M	HGNHL	PR	Yes	20	BM	—
40	44	M	MCL	PR	No	61	BM	—
41	46	M	HGNHL	CR 2	Yes	44	BM	1 Ag C, 1 Ag DQB1^‡
42	50	M	CML	CP1	No	21	BM	1 Ag DRB1
43	41	M	CML	CP1	Yes	43	BM	1 Ag B, 1 Ag DQB1^†
44	49	M	MM	PR	Yes	70	PBSCs	1 Ag C, 1 Ag DQB1^†
45	48	F	CML	CP1	No	21	BM	1 Ag C^†
46	38	M	HD	PR	Yes	83	BM	—
47	47	F	MM	PR	Yes	36	BM	^†

HGNHL indicates high-grade NHL; ALL, acute lymphoblastic leukemia; HD, Hodgkin disease; PCL, plasma cell leukemia; MM, multiple myeloma; LGNHL, low-grade NHL; T-PLL, T-prolymphocytic lymphoma; CMML, chronic myelomonocytic leukemia; MCL, mantle cell lymphoma; PR, partial remission; CP, chronic phase; BM, bone marrow; Ag, antigen.

Time from diagnosis.

†

Serological typing for HLA-A and HLA-B antigens.

‡

HLA disparity unidirectional in host-versus-graft direction.

[ViewLarge]

This Feature Is Available To Subscribers Only